发明名称 Hybrid hydrogel scaffold compositions and methods of use
摘要 The present invention includes new hybrid hydrogel scaffolds comprised of a polyoxyethylene-polyoxypropylene (block) copolymer (a “poloxamer”) and a self-assembling peptide, which maintain the mechanical and bioactive properties of its individual constituents (as compared to when the individual constituents are scaffolds or hydrogels by themselves). The hydrogels of the invention can include a combination of materials from different origins or with different properties that provides a hybrid material that meets the multiple needs of a scaffold for tissue engineering.
申请公布号 US8911723(B2) 申请公布日期 2014.12.16
申请号 US201213592473 申请日期 2012.08.23
申请人 Escape Therapeutics, Inc. 发明人 Hantash Basil M.;Wang Ying
分类号 A61K9/00;A61K38/08;A61K47/34;A61K35/12;C12N5/00 主分类号 A61K9/00
代理机构 Wilmer Cutler Pickering Hale and Dorr LLP 代理人 Wilmer Cutler Pickering Hale and Dorr LLP
主权项 1. A hybrid hydrogel scaffold, the scaffold comprising: (a) about 0.75% to about 1.25% EFK8 (w/v); (b) about 20% poloxamer 407 (w/v); wherein the scaffold provides a microenvironment that: (i) substantially prevents the aggregation of cells, (ii) promotes cell proliferation at a rate that is improved or substantially similar to a hydrogel scaffold made from EFK8 alone, and (iii) has viscoelastic properties that are improved or substantially similar to a hydrogel scaffold made from poloxamer 407 alone; and (c) mesenchymal stem cells; wherein the mesenchymal stem cells are capable of differentiation when the scaffold is transplanted in vivo.
地址 San Jose CA US